ISRCTN76390219
Completed
Not Applicable
A randomised controlled trial comparing the use of sirolimus based biphasic immunosuppression with myfortic to allow early CalciNeurin Inhibitor (CNI) withdrawal in renal transplantatio
niversity Hospitals of Leicester NHS Trust (UK)0 sites42 target enrollmentOctober 16, 2007
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Renal transplantation
- Sponsor
- niversity Hospitals of Leicester NHS Trust (UK)
- Enrollment
- 42
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients will be eligible for the trial if all of the following criteria are met:
- •1\. Age greater than or equal to 18 years
- •2\. Patients receiving a primary or secondary renal allograft from a living related, living unrelated or heart\-beating cadaveric donor
- •3\. Patients with second transplants must have maintained their primary graft for at least six months after transplantation (with the exception of graft failure due to technical reasons)
- •4\. Stable renal allograft function over the first 3 months post transplant
- •5\. An absence of subclinical rejection on the 3 month protocol biopsy
- •6\. A negative pregnancy test pre\-protocol biopsy
- •7\. Signed written informed consent
Exclusion Criteria
- •Patients will not be eligible for the trial if any of the following criteria apply:
- •1\. Kidney transplantation from a non heart\-beating donor
- •2\. Patients suffering an acute rejection episode in the first 3 months post transplant with a Banff classification of 1b or above
- •3\. Sub\-clinical rejection seen in the 3\-month protocol biopsy
- •4\. Proteinuria \>500 mg/24 hours
- •5\. Estimated Glomerular Filtration Rate (eGFR) \<40 mls/min (Cockcroft\-Gault formula)
- •6\. Evidence of active systemic or localised major infection at study entry
- •7\. Known hypersensitivity to Tacrolimus, macrolide antibiotics or Myfortic
- •8\. Use of any investigational drug or treatments within 28 days before study entry
- •9\. Known or suspected malignancy within five years before study entry
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of FemSoft® urethral insert and vaginal tampons for stress urinary incontinenceFemale stress urinary incontinenceUrological and Genital DiseasesStress incontinenceISRCTN97985616Rochester Medical Ltd (UK)90
Unknown
Phase 2
Are drains really necessary for patients undergoing parotid surgery?Health Condition 1: D110- Benign neoplasm of parotid glandHealth Condition 2: null- superficial parotidectomyCTRI/2019/07/020209FLUID RESEARCH GRANT CMC VELLORE45
Completed
Not Applicable
A randomized, controlled trial comparing the use of the Endoflator 50® (KARL STORZ SE & CO. KG) to not preheated opticAll patients had a planned laparoscopy, most common indications were Uterine myoma, Endometriosis and various gynecological malignanciesDRKS00033789niversitätsklinikum des Saarlandes, Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin73
Active, not recruiting
Phase 1
Prospective, randomised trial comparing the use of Tisseel versus no fibrin sealant in preventing postoperative fluid complications following liver resection - Tisseel 1EUCTR2006-002332-17-GBThe Leeds Teaching Hospitals NHS Trust242
Not yet recruiting
Phase 2
A randomised controlled trial evaluating the use of Motivational Interviewing compared to usual care to increase physical activity in people living in the community after a hip fracturehip fracture rehabilitation - increasing activityhip fracture rehabilitation - quality of lifehip fracture rehabilitation - mental healthMusculoskeletal - Other muscular and skeletal disordersACTRN12613000680763Dr Paul O'Halloran from La Trobe University24